Cell Engineering and Analytical Strategies for Control of Recombinant Biopharmaceutical Aggregate Levels in Cell Culture Media
Cell Engineering and Analytical Strategies for Control of Recombinant Biopharmaceutical Aggregate Levels in Cell Culture Media
批准号:
2741298
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --
中文摘要
对于由哺乳动物细胞在培养物中产生的重组蛋白生物药物,蛋白聚集体或寡聚体的形成可能是关于产品质量、功效、免疫原性以及因此的安全性的严重问题。最近的研究(1,2)表明,改变培养环境可以是减少双特异性抗体聚集体形成的有效策略。AZ在盖瑟斯堡(2)阐明的一种潜在机制与补料分批培养期间线粒体功能障碍、活性氧(ROS)蓄积和ER应激介导的三肽谷胱甘肽(GSH)代谢(氧化)受损相关。
英文摘要
For recombinant protein biopharmaceuticals produced by mammalian cells in culture, formation of protein aggregates or oligomers can be severe problem with respect to product quality, efficacy, immunogenicity and therefore safety. Very recent studies (1,2) show that alteration of culture environment can be an effective strategy to reduce the formation of bispecific antibody aggregates. An underlying mechanism, elucidated by AZ at Gaithersburg (2), was shown to be associated with impaired metabolism (oxidation) of the tripeptide glutathione (GSH) mediated by mitochondrial dysfunction, accumulation of reactive oxygen species (ROS) and ER stress during fed-batch culture.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
Frontiers of Environmental Science & Engineering
-
批准号:51224004
-
项目类别:专项基金项目
-
资助金额:20.0万元
-
批准年份:2012
-
负责人:朱建军
-
依托单位:
Chinese Journal of Chemical Engineering
-
批准号:21224004
-
项目类别:专项基金项目
-
资助金额:20.0万元
-
批准年份:2012
-
负责人:廖叶华
-
依托单位:
Chinese Journal of Chemical Engineering
-
批准号:21024805
-
项目类别:专项基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:廖叶华
-
依托单位: